Ensuring Patient Access to Critical Breakthrough Products Act

Sponsored byRep. Moore, Blake D. [R-UT-1]UT· Introduced 15 septembre 2025

Open on Congress.gov

Cosponsors

Actions

Amendments

Committees

—

Since introduced

Introduced

Committee

Passed Chamber

Passed Both

Enacted

Step 0 of 0

Latest action

Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.

17 septembre 2025·10 months ago

Timeline

6 actions

Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.
17 septembre 2025 · Committee
Committee Consideration and Mark-up Session Held
17 septembre 2025 · Committee
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
15 septembre 2025 · IntroReferral
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
15 septembre 2025 · IntroReferral
Introduced in House
15 septembre 2025 · IntroReferral
Introduced in House
15 septembre 2025 · IntroReferral

Sponsorship

62 cosponsors

Sponsor

Rep. Moore, Blake D. [R-UT-1]UT

Cosponsors

Democrat2550%
Republican2550%

Republican:Rep. Dunn, Neal P. [R-FL-2]FL
Democrat:Rep. Stevens, Haley M. [D-MI-11]MI
Republican:Rep. Kim, Young [R-CA-40]CA
Democrat:Rep. Peters, Scott H. [D-CA-50]CA
Republican:Rep. McCormick, Richard [R-GA-7]GA
Democrat:Rep. Scanlon, Mary Gay [D-PA-5]PA
Democrat:Rep. Mrvan, Frank J. [D-IN-1]IN
Republican:Rep. Kelly, Mike [R-PA-16]PA
Republican:Rep. Hern, Kevin [R-OK-1]OK
Republican:Rep. Salazar, Maria Elvira [R-FL-27]FL
Democrat:Rep. Barragán, Nanette Diaz [D-CA-44]CA
Democrat:Rep. Liccardo, Sam T. [D-CA-16]CA
Republican:Rep. Rutherford, John H. [R-FL-5]FL
Republican:Rep. Kustoff, David [R-TN-8]TN
Democrat:Rep. Davids, Sharice [D-KS-3]KS
Republican:Rep. Murphy, Gregory F. [R-NC-3]NC
Democrat:Rep. Mullin, Kevin [D-CA-15]CA
Democrat:Rep. Goodlander, Maggie [D-NH-2]NH
Republican:Rep. Kennedy, Mike [R-UT-3]UT
Democrat:Rep. Boyle, Brendan F. [D-PA-2]PA
Republican:Rep. Ciscomani, Juan [R-AZ-6]AZ
Democrat:Rep. Crow, Jason [D-CO-6]CO
Republican:Rep. Obernolte, Jay [R-CA-23]CA
Republican:Rep. Valadao, David G. [R-CA-22]CA
Democrat:Rep. Whitesides, George [D-CA-27]CA
Republican:Rep. Meuser, Daniel [R-PA-9]PA
Democrat:Rep. Craig, Angie [D-MN-2]MN
Republican:Rep. Joyce, John [R-PA-13]PA
Democrat:Rep. Houlahan, Chrissy [D-PA-6]PA
Democrat:Rep. Cohen, Steve [D-TN-9]TN
Republican:Rep. Maloy, Celeste [R-UT-2]UT
Republican:Rep. Fitzpatrick, Brian K. [R-PA-1]PA
Democrat:Rep. Lofgren, Zoe [D-CA-18]CA
Democrat:Rep. Pettersen, Brittany [D-CO-7]CO
Republican:Rep. Carey, Mike [R-OH-15]OH
Republican:Rep. Lawler, Michael [R-NY-17]NY
Republican:Rep. Malliotakis, Nicole [R-NY-11]NY
Democrat:Rep. Strickland, Marilyn [D-WA-10]WA
Democrat:Rep. Gottheimer, Josh [D-NJ-5]NJ
Republican:Rep. Bentz, Cliff [R-OR-2]OR
Democrat:Rep. Ross, Deborah K. [D-NC-2]NC
Democrat:Rep. Panetta, Jimmy [D-CA-19]CA
Republican:Rep. Bean, Aaron [R-FL-4]FL
Democrat:Rep. Pappas, Chris [D-NH-1]NH
Republican:Rep. Kiggans, Jennifer A. [R-VA-2]VA
Democrat:Rep. Soto, Darren [D-FL-9]FL
Republican:Rep. Weber, Randy K. Sr. [R-TX-14]TX
Democrat:Rep. Bera, Ami [D-CA-6]CA
Republican:Rep. Owens, Burgess [R-UT-4]UT
Democrat:Rep. Lieu, Ted [D-CA-36]CA

View all on Congress.gov

Classification

Policy area

Health

Legislative subjects

Congressional oversightDrug safety, medical device, and laboratory regulationHealth care costs and insuranceHealth care coverage and accessHealth programs administration and fundingHealth technology, devices, suppliesMedicare

Committees

Energy and Commerce Committee
House · Standing
- Referred To15 Sept 2025
Ways and Means Committee
House · Standing
- Referred To15 Sept 2025
- Markup By17 Sept 2025

Track Ensuring Patient Access to Critical Breakthrough Products Act as it moves through Congress